Latest data from September 24, 2021
Number of Health Center respondents = 17 (81% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 3,819 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 39.81% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 755 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 32.83% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 57.87% | 64.50% |
| White, Hispanic/Latino Patients | 18.67% | 12.98% |
| Black/African American, Non-Hispanic/Latino Patients | 5.92% | 4.90% |
| Black/African American, Hispanic/Latino Patients | 0.31% | 0.40% |
| Asian Patients3 | 0.55% | 0.93% |
| American Indian/Alaska Native Patients3 | 6.57% | 5.96% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.18% | 0.26% |
| Patients with More than one race3 | 2.80% | 3.05% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.27% | 3.05% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.20% | 1.19% |
| Unreported/Refused to Report Race and Ethnicity | 2.64% | 2.78% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 987 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 75.59% |
| COVID-19 Immunization Series Completed | 430 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 48.12% |
| COVID-19 Immunization Series Additional | 158 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 18.85% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 21.88% | 44.88% | 62.66% |
| White, Hispanic/Latino Patients | 55.72% | 24.65% | 3.16% |
| Black/African American, Non-Hispanic/Latino Patients | 4.05% | 6.51% | 3.16% |
| Black/African American, Hispanic/Latino Patients | 0.20% | 0.70% | 1.27% |
| Asian Patients3 | 0.51% | 0.47% | 1.90% |
| American Indian/Alaska Native Patients3 | 1.72% | 4.65% | 3.80% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.20% | 1.16% | 0.00% |
| Patients with More than one race3 | 0.41% | 1.16% | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 4.96% | 2.33% | 1.27% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 6.79% | 1.16% | 9.49% |
| Unreported/Refused to Report Race and Ethnicity | 3.55% | 12.33% | 13.29% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 23.53% |
| 1 to 24 Hours | 52.94% |
| More Than 24 Hours | 23.53% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 5.88% |
| Staffing to administer the vaccine | 17.65% |
| Vaccine confidence | 41.18% |
| Vaccine storage capacity | 5.88% |
| Vaccine supply | 0.00% |
| Other | 0.00% |
| None | 41.18% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 101.76% |
| Average Percent of Health Center Visits Conducted Virtually | 12.65% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 5.88% |
| Number of Mobile Van Sites | 0 |
| Number of Pop-up Clinics | 0 |
| Number of School-Based Vaccination Sites | 1 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 47.06% |
| None | 52.94% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 11.76% |
| Patient awareness/education | 23.53% |
| Staffing capacity | 35.29% |
| Therapy administration/onsite logistics | 35.29% |
| Other | 5.88% |
| None | 47.06% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
